HEPATITIS
NEWS The top stories compiled
from over 5,500 sources, updated every 15 minutes
77 more hepatitis cases may trace to clinic, officials say
LAS VEGAS --Seventy-seven more people who were treated at a Las Vegas outpatient clinic have been diagnosed with hepatitis C, health officials said. Authorities can't say for sure how the 77 people were infected, said Brian Labus, senior epidemiologist
77 more hepatitis cases may trace to clinic
LAS VEGAS (AP) - Health officials in Las Vegas say 77 more people who were treated at an outpatient clinic have been diagnosed with hepatitis C. Authorities can't say for sure how the 77 people were infected. Officials say they know each was treated from
Highly Effective Against HCV Genotype 1
When tested on people with Hepatitis C genotype 1, R7128 proved to be an effective addition to combination therapy after just four weeks' time. In addition to its anti-viral effect, polymerase inhibitor R7128 received good marks for safety and minimal...
Investigational Drug Beats Standard Therapy in Hepatitis C Study
A Phase IIa trial investigating triple combination therapy with PEGASYS, COPEGUS and Roche's investigational drug R1626, demonstrated a higher response rate than traditional combination therapy alone. While R1626's effectiveness and high barrier to resistance makes it a top Hepatitis C...
Ascites is the presence of excess fluid in the peritoneal cavity. It
is a common clinical finding with a wide range of causes, but develops most frequently
as a part of the decompensation of previously asymptomatic chronic liver disease.
Pathogenesis
The pathogenesis of ascites formation has several contributing factors that are
listed below.
The clinical manifestations of ascites can vary from an asymptomatic patient to
patients complaining of increased abdominal girth, early satiety, and respiratory
distress depending on the amount of fluid accumulated in the abdomen. On physical
examination presence of ascites is suggested by the following findings:
Abdominal distension
Bulging flanks
Tympany of the top
Fluid wave
Shifting dulness
Puddle sign
Ultrasonography can be peformed to detect or exclude the presence of fluid if
the physical examination is not definitive, since abdominal USG can detect small
amounts of fluid as 100 mL.
Abdominal Paracentesis
Abdominal paracentesis with analysis of the ascitic fluid should be done in patients
with new onset ascites, those requiring hospitalization because of ascites and
those whose condition deteriorates during hospitalization.
Analysis of Ascitic Fluid
The ascitic fluid should be analyzed for:
1.The serum-ascitic albumin gradient (SAAG) is calculated by subtracting the albumim
concentration of the ascitic fluid from the albumin concentration of a serum specimen
obtained on the same day.
2.The amylase concentration which is elevated in pancreatic ascites.
3.The triglyceride concentration which is elevated is chylous ascites.
4.White cell count when greater than 350/microliter is suggestive of infection.
If most cells are polymorphonuclear, bacterial infection should be suspected.
When mononuclear cells predominated , tuberculosis or fungal infection is likely.
5.Red cell count When greater than 50.000/microliter denotes hemorrhagic ascites,
which usually is due to malignancy, tuberculosis or trauma.
6.Gram stain and culture which can confirm the diagnosis of bacterial infection.
7.pH when less than 7 suggests bacterial infection
8.Cytology can be positive in malignancy.
The serum-ascitic albumin gradient correlates directly with portal pressure,
and patients with gradients greater than or equal to 1.1 g/dl have portal hypertension
(transudative ascites) and patients with gradients lesser than 1.1 g/dl do not
(exudative ascites). The total protein concentration of ascitic fluid and LDH
activity has been traditionally used to classify ascitic fluid in exudate or transudate
but they are not so accurate as SAAG. See table 2 with the classification of
types of ascites according to the level of the serum-ascites albumin gradient.
table 2. Types of Ascites according to the level of the serum-ascites albumin
gradient
The treatment of ascites depends on it's cause. In the majority of patients, cirrhosis
leading to portal hypertension is the major cause. A particular value of recognizing
portal hypertension as a cause of ascites is that medical management using diuretics
and salt restriction is often effective in portal hypertensive patients. Conversely,
ascites due to peritoneal inflammation or malignancy alone does not respond to
salt restriction and diuretics.
The treatment can be attempted in an outpatient setting. However hospitalization
may be necessary in three situations:
1.For investigations of the cause of liver disease;
2.Intensive education of the patient in preparing a diet limited to 88 mmol of
sodium per day;
3.Careful monitoring of serum and urine electrolytes and serum concentration of
urea nitrogen and creatinine.
At the hospital it's important to monitoring body weight and the intake and output
of fluids. Fluid restriction is only necessary if the serum sodium concentration
drops below 120 mmol per liter. It is also important to determine the sodium balance
which can be approximated by monitoring intake(diet, sodium-containing medications
and intravenous solutions) and urinary excretion because, a negative sodium balance
is a predictor of weight loss.
A reasonable goal for a patient without peripheral edema is a negative sodium
balance with a weight loss of 0.5 Kg per day.
Drugs
Most patient with cirrhotic ascites respond to dietary sodium restriction and
diuretics. The combination of spironolactone and furosemide is the most effective
regimen for rapid diminution of ascites. The starting dose is 100 mg of Spironolactone
and 40 mg of Furosemide together in the morning. If there is no decrease in body
weight or increase in urinary sodium excretion after two or three days, the doses
of both drugs should be increased. The doses of medication can be increased to
400 mg of Spironolactone per day and 160 mg of Furosemide per day.
Only 10% of patients do not respond to this medical approach (diuretics plus dietary
sodium restriction) and in those who respond no other treatment for ascites is
needed as long as it continues to be effective.
Diuretic-Resistant Ascites
Treatment options for ascites resistant to medical therapy include:
Therapeutic Paracentesis
LeVeen or Denver(peritoneovenous) shunt
Liver transplantation
Extracorporeal ultrafiltration of ascitic fluid with reinfusion
Transjugular intrahepatic portosystemic stent shunt
Therapeutic Paracentesis
Paracentesis of up to 1 L of fluid may provide relief of acute respiratory embarrassment
secondary to tense ascites. Removal of greater volumes and total paracentesis (largest
reported volume, 22,5 L) are subject of discussion since some authors advocate
the replacement of 10 g of albumin intravenously for each 1 L of ascitic fluid
removed in order to prevent a reduction in plasma volume, abnormalities of electrolytes
and creatinine. However it is not clear if the use of albumin or others volume
expanders such as Dextran affects the morbidity and mortality.
References
Runyon BA : Care of patients with ascites. New England Journal of
Medicine 330:337, 1994.
Runyon BA, Montano AA, Akriviadis EA et al : The serum-ascites gradient is superior
to the exsudate-transudate concept in differential diagnosis of ascites. Ann Intern
Med 117:215, 1992.
Diseases of the peritoneum, mesentery and omentum. In Wynngaarden JB, Smith LH,
Bennet JC(eds): Cecil Textbook of Medicine, 20th edition. W B Saunders Company,
1996.
Cirrhosis of the liver and its major sequelae. In Wynngaarden JB, Smith LH, Bennet
JC(eds): Cecil Textbook of Medicine, 20th edition. W B Saunders Company, 1996.
Information at this website is for educational purposes
only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.